Max Multi Silver
Max Multi Silver, licence 80033917: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Natural Equivalents Incorporated
- NPN or DIN-HM
- 80033917
- Status
- Inactive licence
- Licence date
- 24 July 2012
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serenoa repens Source : Fruit Extraction ratio : 4:1 Dry plant equivalent : 504 mg | 126.0 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 3.0 mg | Not calculated |
| Vitamine A Source : Acétate de vitamine A Potency : 4965.0 UI Vitamin A | 1469.23 µg RAE | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle Potency : 45.0 UI Vitamin E | 30.15 mg AT | Not calculated |
| Acide pantothénique Source : Dexpanthénol | 6.0 mg | Not calculated |
| Bêta-carotène Source : Bêta carotène Potency : 5001.0 UI Beta-carotene | 3000.0 µg | Not calculated |
| Medicago sativa Source : Parties aériennes Extraction ratio : 8:1 Dry plant equivalent : 810 mg | 101.25 mg | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 150.0 mg | Not calculated |
| Boron Source : Sodium borate | 60.0 µg | Not calculated |
| Withania somnifera Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 2025 mg | 405.0 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extraction ratio : 25:1 Dry plant equivalent : 2040 mg | 81.6 mg | Not calculated |
| Cuivre Source : Sulfate cuivrique anhydre | 900.0 µg | Not calculated |
| Eleutherococcus senticosus Source : Racine Extraction ratio : 50:1 Dry plant equivalent : 975 mg | 19.5 mg | Not calculated |
| Niacinamide Source : Niacinamide | 18.0 mg | Not calculated |
| Molybdène Source : Molybdate de sodium (VI) dihydraté | 45.0 µg | Not calculated |
| Silicium Source : Dioxyde de silicium | 15.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 4.0 % Terpene lactones | Not specified | Not calculated |
Non-medicinal ingredients
Natural Berry Flavour, Gomme de xanthane, Feuille de stevia rebaudiana, Glycérine, gomme acacia, Eau purifiée, Sorbate de potassium, xylitol, Saveur de fraise
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Cuillière(s) à table | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Multi-vitamin/mineral supplement for the maintenance of good health. Ashwagandha is traditionally used in Ayurveda as Rasayana (rejuvenative tonic). Fenugreek is traditionally used in Herbal Medicine as a nutritive tonic. Used in Herbal Medicine as a tonic to help relieve general debility and/or to aid during convalescence. Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80033917
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.